Patent delisted for Merck Sharp drug PREVYMIS

Copyright © DrugPatentWatch. Originally published at

Annual Drug Patent Expirations for PREVYMIS
Prevymis is a drug marketed by Merck Sharp Dohme and is included in two NDAs. It is available from one supplier. There are three patents protecting this drug.

This drug has seventy patent family members in forty-four countries.

The generic ingredient in PREVYMIS is letermovir. One supplier is listed for this compound. Additional details are available on the letermovir profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact or visit

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top